Skip to main content

UBS Group AG

Position in ATYR — aTYR PHARMA INC

CIK 1610520 ZURICH, V8

Position in ATYR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$914,096
-$2,102,330 QoQ
Shares Held
1,531,151
-60.4% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 90 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATYR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ATYR ranks #267 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATYR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $914,096 1,531,151
2026-03-31 $3,016,426 3,867,213
2025-12-31 $1,272,607 1,625,297
2025-09-30 $3,248,792 4,505,955
2025-06-30 $8,850,785 1,745,717
2025-03-31 $4,944,300 1,637,186
2024-12-31 $831,065 229,576
2024-03-31 $39,374 20,192
2023-12-31 $23,160 16,426
2023-09-30 $6,950 4,399
2023-03-31 $2,100 1,000
2022-09-30 $17,925 5,975
2022-06-30 $5,660 2,000
2022-03-31 $21,400 4,000
2021-12-31 $8,456 1,132
2021-06-30 $15,440 3,164
2020-09-30 $5,287 1,637
2020-06-30 $177,817 40,049
2020-03-31 $106,397 37,999